Take our poll: How does Breast Cancer Awareness Month make you feel?
Donate to Breastcancer.org when you checkout at Walgreens in October. Learn more about our Walgreens collaboration.

Lynparza Approved To Treat High-Risk, Early-Stage, HER2-, BRCA+

moderators
moderators Posts: 8,570
edited May 15 in Genetic Testing

Lynparza Approved To Treat High-Risk, Early-Stage, HER2-Negative Breast Cancer With BRCA Mutation
Mar 13, 2022
The FDA approved Lynparza to treat early-stage, HER2-negative breast cancer with a BRCA1 or BRCA2 mutation and a high risk of recurrence, which also has been previously treated with chemotherapy — either before or after surgery. Read more...

Tagged:

Comments

  • katg
    katg Member Posts: 247

    I had not read this before. After having pancytopenia from 12 rounds of two chemos and one round of AC, i was given a different olarib pill. A cousin of Lynparza. That made my blood numbers dive again. Interesting, I went on Lynparza 6 months later for 1 year at a lower dose then . BRCA2 and Her 2+. Was i already developing MDS?

Categories

Join Us on Zoom: Upcoming virtual meetups. Read more...
Give your account some personality! Add a profile photo.